Sampre Nutritions Share Price

Sampre Nutritions Share Price

  • 9.44-0.49 (-4.93%)
BSE
  • Closed
  • As On: 16 Jun, 2026, 03:40 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)27.21
EPS - TTM(₹)0.35
MCap(₹ Cr.)89.69
MCap Rank50
PB Ratio(x)0.88
Div Yield(%)-
Face Value(₹)5.00
52W High(₹)42.32
52W Low(₹)6.67
MCap/Sales3.79
Beta(1 Month)-0.08
BV/Share(₹)11.30

Sampre Nutrition share price insights

  • Quarterly Topline Performance

    Company witnessed QoQ revenue growth of 113.63%, which is highest in the last 3 years. (Source: Standalone Financials)
  • Beating 3 Yr Revenue CAGR

    Company's annual revenue growth of 71.69% outperformed its 3 year CAGR of 5.54%. (Source: Consolidated Financials)
  • Employee & Interest Expense

    Company has spent 3.16% of its operating revenues towards interest expenses and 30.84% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Sampre Nutrition Share Price Update

    Sampre Nutritions Ltd. share price moved down by -4.93% from its previous close of Rs 9.93. Sampre Nutritions Ltd. stock last traded price is 9.44

    Share PriceValue
    Today/Current/Last9.44
    Previous Day9.93

Found Insights useful?

Sampre Nutrition Share Price Returns

1 Day-4.93%
1 Month-35.12%
3 Months-57.91%
1 Year41.48%
3 Years-57.1%
5 Years113.94%

Sampre Nutrition Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income15.507.3910.0010.898.07
    Total Income Growth (%)109.86-26.16-8.1634.9543.56
    Total Expenses15.216.408.669.8814.70
    Total Expenses Growth (%)137.66-26.06-12.35-32.81163.49
    EBIT0.290.991.351.02-6.63
    EBIT Growth (%)-70.80-26.8632.59-0.00
    Profit after Tax (PAT)1.070.620.900.71-7.35
    PAT Growth (%)74.04-31.1326.70--
    EBIT Margin (%)1.8613.3413.469.33-82.11
    Net Profit Margin (%)6.938.368.966.50-91.12
    Basic EPS (₹)0.640.060.410.34-3.50
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income15.787.3910.0010.898.07
    Total Income Growth (%)113.63-26.16-8.1634.9543.56
    Total Expenses14.746.368.669.8714.72
    Total Expenses Growth (%)131.81-26.55-12.32-32.92164.11
    EBIT1.041.031.341.02-6.65
    EBIT Growth (%)0.92-23.7132.18-0.00
    Profit after Tax (PAT)1.820.660.890.71-7.14
    PAT Growth (%)176.78-26.4126.12--
    EBIT Margin (%)6.5613.8913.459.34-82.38
    Net Profit Margin (%)11.558.918.946.51-88.50
    Basic EPS (₹)0.870.070.410.34-3.40
    FY 2026FY 2025FY 2024
    Total Revenue43.7825.5025.26
    Total Revenue Growth (%)71.690.93-32.05
    Total Expenses42.0033.0224.78
    Total Expenses Growth (%)27.1933.28-32.60
    Profit after Tax (PAT)3.08-7.670.23
    PAT Growth (%)--3,412.74-33.33
    Operating Profit Margin (%)7.25-21.729.58
    Net Profit Margin (%)7.09-30.530.92
    Basic EPS (₹)1.46-5.430.34
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue44.0625.5025.2637.1823.40
    Total Revenue Growth (%)72.780.93-32.0558.8628.13
    Total Expenses41.4932.6624.7036.7623.03
    Total Expenses Growth (%)27.0432.23-32.8159.6226.85
    Profit after Tax (PAT)3.87-7.310.310.350.31
    PAT Growth (%)--2,461.62-10.8112.70307.40
    Operating Profit Margin (%)9.07-21.219.886.219.24
    Net Profit Margin (%)8.91-29.091.230.931.33
    Basic EPS (₹)1.84-3.480.430.610.64

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Quarterly Topline Performance

      Company witnessed QoQ revenue growth of 113.63%, which is highest in the last 3 years. (Source: Standalone Financials)
    • Beating 3 Yr Revenue CAGR

      Company's annual revenue growth of 71.69% outperformed its 3 year CAGR of 5.54%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024
    Total Assets134.38115.4344.75
    Total Assets Growth (%)16.41157.932.67
    Total Liabilities27.0224.5622.28
    Total Liabilities Growth (%)10.0310.21-0.65
    Total Equity107.3690.8822.47
    Total Equity Growth (%)18.13304.456.20
    Current Ratio (x)1.601.171.31
    Total Debt to Equity (x)0.170.190.78
    Contingent Liabilities0.00--
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets126.98117.0844.8343.5937.70
    Total Assets Growth (%)8.46161.162.8415.62-1.54
    Total Liabilities26.7424.5222.2822.4326.61
    Total Liabilities Growth (%)9.0510.05-0.67-15.71-3.24
    Total Equity100.2492.5622.5521.1611.09
    Total Equity Growth (%)8.30310.476.5790.802.88
    Current Ratio (x)1.631.161.291.461.08
    Total Debt to Equity (x)0.180.180.780.791.91
    Contingent Liabilities0.00----

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024
    Net Cash flow from Operating Activities-1.100.083.95
    Net Cash used in Investing Activities-2.75-75.17-3.70
    Net Cash flow from Financing Activities3.7075.03-0.09
    Net Cash Flow-0.15-0.050.16
    Closing Cash & Cash Equivalent0.080.230.28
    Closing Cash & Cash Equivalent Growth (%)-64.61-18.51126.13
    Total Debt/ CFO (x)-16.33200.294.43
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-0.940.094.030.882.41
    Net Cash used in Investing Activities-2.75-75.17-3.95-4.32-0.76
    Net Cash flow from Financing Activities3.7075.03-0.093.48-1.66
    Net Cash Flow0.01-0.05-0.020.04-0.01
    Closing Cash & Cash Equivalent0.060.060.110.130.08
    Closing Cash & Cash Equivalent Growth (%)11.01-47.68-14.5452.61-15.22
    Total Debt/ CFO (x)-19.04196.564.3419.098.82

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 2.75 cr for investing activities which is an YoY decrease of 96.34%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024
    Return on Equity (%)2.86-8.441.03
    Return on Capital Employed (%)2.61-5.347.39
    Return on Assets (%)2.28-6.640.51
    Interest Coverage Ratio (x)3.79-1.692.21
    Asset Turnover Ratio (x)0.350.310.57
    Price to Earnings (x)53.76-6.14217.39
    Price to Book (x)1.530.522.20
    EV/EBITDA (x)35.12-18.2815.73
    EBITDA Margin (%)11.97-13.8816.87
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)3.85-7.891.371.642.77
    Return on Capital Employed (%)3.48-5.127.617.128.77
    Return on Assets (%)3.04-6.240.690.790.81
    Interest Coverage Ratio (x)4.37-1.832.252.192.14
    Asset Turnover Ratio (x)0.360.310.570.910.61
    Price to Earnings (x)42.74-6.45161.29181.8251.02
    Price to Book (x)1.640.512.202.961.41
    EV/EBITDA (x)30.49-19.0415.5019.229.76
    EBITDA Margin (%)13.79-13.3617.1711.1216.31

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters1,33,36,65214.04 %-1.22
    Pledge00.00 %0.00
    FII4,11,0000.43 %-
    Others8,12,61,26185.53 %0.79
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters14.0415.2612.1112.11
    Pledge0.000.000.000.00
    FII0.430.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others85.5384.7487.8987.89

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 27, 2026

    General Meeting

    -

    Apr 10, 2026

    Board Meeting

    Quarterly Results

    Feb 11, 2026

  • Announced onMeeting on
    May 27, 2026May 29, 2026
    Audited Results
    Feb 11, 2026Feb 13, 2026
    Quarterly Results
    Nov 03, 2025Nov 05, 2025
    Quarterly Results & Others
    Sep 30, 2025Oct 03, 2025
    Others
    Sep 15, 2025Sep 19, 2025
    Bonus issue & Stock Split
  • Announced onEx-DateDividend%
    Jul 03, 2002-0%
  • Announced onEx-Date
    Sep 19, 2025Nov 14, 2025
    Bonus Ratio: 1 share(s) for every 1 shares held
  • Announced onEx-Date
    Sep 19, 2025Nov 14, 2025
    Split: Old FV10.0| New FV:5.0
  • Announced onEx-Date
    Mar 10, 2022-
    Rights ratio: 2 share for every 1 held at a price of Rs 15.0
  • Announced onMeeting on
    Apr 10, 2026May 12, 2026
    -
    Nov 19, 2025Dec 10, 2025
    -
    Sep 29, 2025Oct 28, 2025
    -
    Sep 01, 2025Sep 23, 2025
    -
    Nov 04, 2024Nov 30, 2024
    -

About Sampre Nutrition

Sampre Nutritions Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 89.69 Crore) operating in FMCG sector.

Show More

Industry

FMCG Others

Key Indices Listed On

-

Address

Plot No. 133,Industrial Estate,Ranga Reddy District, Telangana - 500401

Executive Leadership

BG

Brahma Gurbani

Managing Director
VR

Vishal Ratan Gurbani

WholeTime Director & V P
B

Banala Jayprakash Reddy

Independent Director
KM

Kireet Modi

Independent Director
Show More

Auditors

N G Rao & Associates
RRK & Associates

FAQs about Sampre Nutrition share

  • 1. What's Sampre Nutrition share price today and what are Sampre Nutrition share returns ?
    Sampre Nutrition share price is Rs 9.44 as on 16 Jun, 2026, 03:40 PM IST. Sampre Nutrition share price is down by 4.93% based on previous share price of Rs 10.45. Sampre Nutrition share price trend:
    • Last 3 Years: Sampre Nutrition Share price moved down by 57.10%
  • 2. What is the market cap of Sampre Nutrition?
    Sampre Nutrition share has a market capitalization of Rs 89.69 Cr. Within FMCG sector, it's market cap rank is 50.
  • 3. What are the returns for Sampre Nutrition share?
    Return Performance of Sampre Nutrition Shares:
    • 1 Week: Sampre Nutrition share price moved down by 14.42%
  • 4. What is the PE & PB ratio of Sampre Nutrition?
    The PE ratio of Sampre Nutrition stands at 28.62, while the PB ratio is 0.88.
  • 5. What is 52 week high/low of Sampre Nutrition share price?
    Sampre Nutrition share price saw a 52 week high of Rs 42.32 and 52 week low of Rs 6.67.

Top Gainers

As on 03:59 PM | 16 Jun 2026
Sonata Software
311.25
50.90 (19.56%)
FACT
997.80
91.75 (10.13%)
MMTC
75.74
5.55 (7.91%)
PG Electroplast
527.45
34.66 (7.04%)
Century Texttiles
1,315.70
75.71 (6.11%)

Top Losers

As on 04:01 PM | 16 Jun 2026
GIC
358.40
-28.86 (-7.45%)
PTC Industries
17,809.00
-847.00 (-4.55%)
NALCO
366.65
-15.71 (-4.11%)
Akums Drugs & Pharma
596.85
-23.11 (-3.73%)
Minda Ind.
1,089.50
-36.21 (-3.22%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.